PIONEERS IN PLASMA SURGERY & MEDICINE
MEDIA
LATEST PRESS RELEASES
JCRI – ABTS and USMI to Present a Two-year Follow-up of Phase I Clinical Trial Using Cold Atmospheric Plasma for the Treatment of Solid Tumors at Israeli Society of Surgical Oncology
Takoma Park, MD
Read Press Release
JCRI DISCOVERS REGULATORY GENE BCL2A1 FOR TREATMENT OF TRIPLE-NEGATIVE BREAST CANCER
Takoma Park, MD
Read Press Release
USMI and JCRI Research Teams Develop Treatment System for COVID and other Respiratory Infections and Diseases
Takoma Park, MD
Read Press Release
USMI to Announce Successful Results of Phase I Clinical Trial Using Cold Atmospheric Plasma for the Treatment of Solid Tumors at the Baird 2021 Global Healthcare Conference
Takoma Park, MD
Read Press Release
RECENT PUBLICATIONS
The Granger Causal Effects of Canady Helios Cold Plasma on the Inhibition of Breast Cancer Cell Proliferation
By Annisa Elbedour, Xiaoqian Cheng, Saravana R. K. Murthy, Taisen Zhuang, Lawan Ly, Olivia Jones, Giacomo Basadonna, Michael Keidar and Jerome Canady
JCRI DISCOVERS REGULATORY GENE BCL2A1 FOR TREATMENT OF TRIPLE-NEGATIVE BREAST CANCER
By Saravana R.K. Murthy, Taisen Zhuang, Xiaoqian Cheng, Lawan Ly, Olivia Jones, Giacomo Basadonna, Michael Keidar and Jerome Canady
Canady Biotechnology proudly manufactures our products in the USA
Keep America Strong
6930 Carroll Avenue, Suite 1000
Takoma Park, Maryland 20912
US Medical Innovations, LLC (USMI), based out of Takoma Park, MD, is a privately-held FDA registered life science and biomedical device company. USMI is dedicated to expanding the boundaries of plasma medicine by pioneering new technologies for the development of state-of-the-art medical devices that advance patient outcomes and improve human lives.